Alternate site health provider Option Care Health (NASDAQ: OPCH) missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.3% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.73 billion at the midpoint came in 3.6% below analysts’ estimates. Its non-GAAP profit of $0.40 per share was 8.1% above analysts’ consensus estimates.

Is now the time to buy Option Care Health? Find out by accessing our full research report, it’s free.

“The first quarter reflected a mixed performance for our business, and we are not satisfied with our revenue growth momentum,” commented John C. Rademacher, President & Chief Executive Officer, Option Care Health.

Company Overview

With a nationwide network of 177 locations serving 43 states and a team of over 4,500 clinicians, Option Care Health (NASDAQ: OPCH) is the largest independent provider of home and alternate site infusion services, delivering medications and clinical support to patients across the United States.

Revenue Growth

Examining a company’s long-term performance can provide clues about its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Thankfully, Option Care Health’s 12.9% annualized revenue growth over the last five years was solid. Its growth beat the average healthcare company and shows its offerings resonate with customers.

We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. Option Care Health’s annualized revenue growth of 13.1% over the last two years aligns with its five-year trend, suggesting its demand was predictably strong.

This quarter, Option Care Health’s revenue grew by 1.3% year on year to $1.35 billion, falling short of Wall Street’s estimates.

Looking ahead, sell-side analysts expect revenue to grow 6.9% over the next 12 months, a deceleration versus the last two years. Despite the slowdown, this projection is above the sector average and suggests the market is forecasting some success for its newer products and services.

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.

Adjusted Operating Margin

Adjusted operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It’s also useful for comparing profitability across companies because it excludes non-recurring expenses, interest on debt, and taxes.

Option Care Health’s adjusted operating margin has more or less stayed the same over the last 12 months , averaging 7.1% over the last five years. This profitability was mediocre for a healthcare business and caused by its suboptimal cost structure.

Analyzing the trend in its profitability, Option Care Health’s adjusted operating margin might fluctuated slightly but has generally stayed the same over the last five years. This raises questions about the company’s expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability.

In Q1, Option Care Health generated an adjusted operating margin profit margin of 6.1%, down 1.2 percentage points year on year. This reduction is quite minuscule and indicates the company’s overall cost structure has been relatively stable.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions.

Option Care Health’s EPS grew at 41.6% compounded annual growth rate over the last five years, higher than its 12.9% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.

Diving into the nuances of Option Care Health’s earnings can give us a better understanding of its performance. A five-year view shows that Option Care Health has repurchased its stock, shrinking its share count by 12%. This tells us its EPS outperformed its revenue not because of increased operational efficiency but financial engineering, as buybacks boost per share earnings.

In Q1, Option Care Health reported adjusted EPS of $0.40, in line with the same quarter last year. This print beat analysts’ estimates by 8.1%. Over the next 12 months, Wall Street expects Option Care Health’s full-year EPS of $1.72 to grow 12.4%.

Key Takeaways from Option Care Health’s Q1 Results

It was good to see Option Care Health beat analysts’ EPS expectations this quarter. On the other hand, its full-year revenue guidance missed and its revenue fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 14.4% to $23 immediately following the results.

Option Care Health’s latest earnings report disappointed. One quarter doesn’t define a company’s quality, so let’s explore whether the stock is a buy at the current price. When making that decision, it’s important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here (it’s free).